The initiative is focused on evaluating technologies that enhance motor and cognitive rehabilitation for patients affected by stroke, traumatic brain injury, and neurological disorders. Selected solutions will be assessed in a real-world clinical setting, with attention to their effectiveness, usability, integration, and scalability.
Selected SMEs:
- EGZOTech Sp. z o.o. (Poland)
EGZOTech brings the EgzoConcept, a suite of robotic rehabilitation devices enhanced with EMG-triggered electrostimulation and biofeedback-driven therapy games.
Their portfolio includes systems like Luna EMG, Meissa OT, and Sidra LEG, targeting the recovery of both upper and lower body functions.
Key features:
• Devices for strength training, neuromuscular re-education, and EMG biofeedback
• Suitable for patients with stroke, cerebral palsy, or spinal cord injuries
• Modular and mobile equipment tailored to clinical use
• Gamified interfaces to enhance therapy adherence
- MEEVA Srl Società Benefit (Italy)
MEEVA will present an immersive Virtual Reality (VR) system designed to reduce anxiety and regulate emotions in individuals with cognitive impairments.
The solution offers naturalistic, therapist-controlled environments that support both emotional and psychological rehabilitation.
It has demonstrated high tolerability and clinical effectiveness in both pilot studies and randomized trials.
Key strengths:
• Customizable scenarios for guided breathing and relaxation
• High patient engagement and memory recall
• Suitable for older adults, stroke survivors, and dementia patients
- Technomex Sp. z o.o. (Poland)
Technomex is one of Europe’s leading developers of rehabilitation and medical equipment, with a portfolio that includes robotic and sensor-based technologies. At San Camillo, the company will showcase state-of-the-art systems combining biofeedback, motion analysis, and gamified therapy modules to support recovery across various conditions.
Key strengths:
• Advanced robotics for upper and lower limb therapy
• Integration of virtual reality and feedback systems
• Strong presence in rehabilitation centers across Europe
• Proven usability in both inpatient and outpatient settings
The technologies will be showcased and assessed at IRCCS San Camillo Hospital, Venice, focusing on:
• Clinical feasibility and therapeutic effectiveness
• Ease of use for patients and care professionals
• Integration into care workflows and potential for scaling up
This regional pilot contributes to RehAllianCE’s broader goal of accelerating smart health innovation and strengthening the digital rehabilitation ecosystem across Central Europe.